The use of high-sensitivity assays for C-reactive protein in clinical practice

被引:110
|
作者
Musunuru, Kiran [1 ]
Kral, Brian G.
Blumenthal, Roger S. [1 ]
Fuster, Valentin [2 ,3 ]
Campbell, Catherine Y.
Gluckman, Ty J.
Lange, Richard A. [1 ]
Topol, Eric J. [4 ]
Willerson, James T. [5 ]
Desai, Milind Y. [6 ,7 ]
Davidson, Michael H. [8 ]
Mora, Samia [9 ,10 ]
机构
[1] Johns Hopkins Univ, Sch Med, Johns Hopkins Ciccarone Prevent Cardiol Ctr, Baltimore, MD 21287 USA
[2] Mt Sinai Sch Med, Zena & Michacl A Wiener Cardiovasc Inst, New York, NY USA
[3] Mt Sinai Sch Med, Marie Jose & Henry R Kravis Ctr Cardiovasc Hlth, New York, NY USA
[4] Scripps Translat Sci Inst, La Jolla, CA USA
[5] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA
[6] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
[7] Case Western Reserve Univ, Lerner Coll Med, Cleveland, OH 44106 USA
[8] Univ Chicago, Sch Med, Chicago, IL 60637 USA
[9] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent, Boston, MA 02115 USA
[10] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA
来源
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2008年 / 5卷 / 10期
关键词
coronary disease; diabetes mellitus; prevention; risk factors; stroke;
D O I
10.1038/ncpcardio1322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High-sensitivity assays that accurately measure levels of the inflammatory biomarker C-reactive protein have been proposed for use in assessments of risk for cardiovascular disease (CVD). A growing body of evidence supports recommendations for these tests in selected asymptornatic individuals deemed to be at intermediate risk of CVD according to traditional risk-factor assessments and who do not already warrant chronic treatment with aspirin and statin therapy. Data suggests that these high-sensitivity assays should be used in combination with measurements of LDL-cholesterol levels to assist risk stratification of selected patients for prevention of CVD.
引用
收藏
页码:621 / 635
页数:15
相关论文
共 50 条
  • [1] The use of high-sensitivity assays for C-reactive protein in clinical practice
    Kiran Musunuru
    Brian G Kral
    Roger S Blumenthal
    Valentin Fuster
    Catherine Y Campbell
    Ty J Gluckman
    Richard A Lange
    Eric J Topol
    James T Willerson
    Milind Y Desai
    Michael H Davidson
    Samia Mora
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 : 621 - 635
  • [2] Agreement between high-sensitivity C-reactive protein and C-reactive protein assays
    Han, E.
    Fritzer-Szekeres, M.
    Szekeres, T.
    Anvari-Pirsch, A.
    Gyoengyoesi, M.
    Bergler-Klein, J.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1084 - 1084
  • [3] Agreement between high-sensitivity c-reactive protein and c-reactive protein assays
    Han, E.
    Fritzer-Szekeres, M.
    Szekeres, T.
    Anvari-Pirsch, A.
    Gyoengyoesi, M.
    Bergler-Klein, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 3) : S91 - S92
  • [4] Limited clinical utility of high-sensitivity plasma C-reactive protein assays
    Elfatih, A
    Chatha, K
    Anderson, NR
    Gama, R
    ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 : 536 - 537
  • [5] Limited clinical utility of high-sensitivity plasma C-reactive protein assays
    Campbell, B
    Badrick, T
    Flatman, R
    Kanowski, D
    ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 : 85 - 88
  • [6] Point - High-sensitivity C-reactive protein and cardiac C-reactive protein assays: Is there a need to differentiate?
    Rifai, Nader
    Ballantyne, Christie M.
    Cushman, Mary
    Levy, Daniel
    Myers, Gary L.
    CLINICAL CHEMISTRY, 2006, 52 (07) : 1254 - 1256
  • [7] High-sensitivity C-reactive protein: Clinical importance
    Bassuk, SS
    Rifai, N
    Ridker, PM
    CURRENT PROBLEMS IN CARDIOLOGY, 2004, 29 (08) : 439 - 493
  • [8] The Application of High-Sensitivity C-Reactive Protein in Clinical Practice A 2015 Update
    Knight, Michelle L.
    US PHARMACIST, 2015, 40 (02) : 50 - 53
  • [9] C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians
    Windgassen, Elizabeth B.
    Funtowicz, Luciana
    Lunsford, Tisha N.
    Harris, Lucinda A.
    Mulvagh, Sharon L.
    POSTGRADUATE MEDICINE, 2011, 123 (01) : 114 - 119
  • [10] High-Sensitivity C-Reactive Protein and Cancer
    Lee, Seounghee
    Choe, Jae-Won
    Kim, Hong-Kyu
    Sung, Joohon
    JOURNAL OF EPIDEMIOLOGY, 2011, 21 (03) : 161 - 168